These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7879822)
21. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267 [TBL] [Abstract][Full Text] [Related]
22. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053 [TBL] [Abstract][Full Text] [Related]
23. HLA-linked heat-shock protein 70 (HSP70-2) gene polymorphism and celiac disease. Partanen J; Milner C; Campbell RD; Mäki M; Lipsanen V; Koskimies S Tissue Antigens; 1993 Jan; 41(1):15-9. PubMed ID: 8096093 [TBL] [Abstract][Full Text] [Related]
24. [Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype]. Jurcić Z; Brkljacić-Surkalović L; Grubić Z; Zunec R; Vezmar V; Kastelan A Lijec Vjesn; 2000; 122(11-12):259-63. PubMed ID: 11291267 [TBL] [Abstract][Full Text] [Related]
25. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Mearin ML; Bouquet J; Mourad N; Schoorel E; Sinaasappel M; Biemond I; Schreuder GM; Peña AS; van Gelderen HH; van Rood JJ Clin Genet; 1985 Jan; 27(1):45-50. PubMed ID: 3872185 [TBL] [Abstract][Full Text] [Related]
26. Celiac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw1. Hall MA; Lanchbury JS; Bolsover WJ; Welsh KI; Ciclitira PJ Hum Immunol; 1990 Mar; 27(3):220-8. PubMed ID: 1971269 [TBL] [Abstract][Full Text] [Related]
27. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667 [TBL] [Abstract][Full Text] [Related]
28. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility. Fletcher J; Franklyn JA; McLachlan SM; Young E; Sheppard MC Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104 [TBL] [Abstract][Full Text] [Related]
29. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus. Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231 [TBL] [Abstract][Full Text] [Related]
31. An HLA-D region restriction fragment length polymorphism associated with celiac disease. Howell MD; Austin RK; Kelleher D; Nepom GT; Kagnoff MF J Exp Med; 1986 Jul; 164(1):333-8. PubMed ID: 3014038 [TBL] [Abstract][Full Text] [Related]
32. HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects. Demarchi M; Carbonara A; Ansaldi N; Santini B; Barbera C; Borelli I; Rossino P; Rendine S Gut; 1983 Aug; 24(8):706-12. PubMed ID: 6603391 [TBL] [Abstract][Full Text] [Related]
33. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Bilbao JR; Calvo B; Aransay AM; Martin-Pagola A; Perez de Nanclares G; Aly TA; Rica I; Vitoria JC; Gaztambide S; Noble J; Fain PR; Awdeh ZL; Alper CA; Castaño L Genes Immun; 2006 Oct; 7(7):550-4. PubMed ID: 16929349 [TBL] [Abstract][Full Text] [Related]
34. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921 [TBL] [Abstract][Full Text] [Related]
35. Linkage of HLA-DR beta specific restriction fragment length polymorphisms with Graves' disease. Boehm BO; Schifferdecker E; Kuehnl P; Schöffling K Acta Endocrinol (Copenh); 1988 Oct; 119(2):251-6. PubMed ID: 2902722 [TBL] [Abstract][Full Text] [Related]
37. HLA-DR3- and HLA-DR7-restricted T-cell hyporesponsiveness to gluten antigen: a clue to the aetiology of coeliac disease? Scott H; Hirschberg H; Thorsby E Scand J Immunol; 1983 Aug; 18(2):163-7. PubMed ID: 6603652 [TBL] [Abstract][Full Text] [Related]
38. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta. Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476 [TBL] [Abstract][Full Text] [Related]
39. Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Howe HS; So AK; Farrant J; Webster AD Clin Exp Immunol; 1991 Mar; 83(3):387-90. PubMed ID: 1672269 [TBL] [Abstract][Full Text] [Related]
40. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]